Literature DB >> 20728714

Prevalence and activity of Epstein-Barr virus and human cytomegalovirus in symptomatic and asymptomatic apical periodontitis lesions.

Katinka Hernádi1, Anita Szalmás, Richárd Mogyorósi, Levente Czompa, György Veress, Eszter Csoma, Ildikó Márton, József Kónya.   

Abstract

INTRODUCTION: Apical periodontitis is a polymicrobial inflammation with a dominant flora of opportunistic Gram-negative bacteria; however, a pathogenic role of human herpesviruses such as Epstein-Barr virus (EBV) and human cytomegalovirus (HCMV) has been implicated recently. The aims of this study were to determine the prevalence, activity, and disease association of EBV and HCMV in apical periodontitis in an Eastern Hungarian population.
METHODS: Forty samples with apical periodontitis (17 symptomatic and 23 asymptomatic) and 40 healthy pulp controls were collected. EBV and HCMV prevalences were measured by polymerase chain reaction (PCR) detection of the viral DNA and viral activity was tested by reverse-transcription PCR amplification of viral messenger RNA.
RESULTS: EBV DNA and EBNA-2 messenger RNA were found in apical periodontitis lesions at significantly (p < 0.0001) higher frequencies (72.5% and 50%, respectively) than in controls (both 2.5%). The occurrence of HCMV infection was rare in both apical lesions (10%) and controls (0%). The presence of EBV DNA in apical lesions was associated significantly with large (> or = 5 mm) lesion size (p = 0.02) but not with symptoms (p = 0.30). Symptomatic manifestation was significantly associated with the co-occurrence (odds ratio [OR], 8.80; 95% confidence interval [CI], 1.69-45.76) but not the sole occurrences of EBNA-2 messenger RNA (OR, 2.29; 95% CI, 0.48-11.06) and large lesion size (OR, 4.02; 95% CI, 0.81-19.89).
CONCLUSION: EBV infection is a frequent event in apical periodontitis, whereas the involvement of HCMV still remains to be elucidated. This study showed that symptomatic manifestation was likely to occur if a large-sized apical periodontitis lesion is aggravated with active EBV infection. Copyright 2010 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20728714     DOI: 10.1016/j.joen.2010.06.008

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  6 in total

Review 1.  Viruses in pulp and periapical inflammation: a review.

Authors:  Scarlette Hernández Vigueras; Manuel Donoso Zúñiga; Enric Jané-Salas; Luis Salazar Navarrete; Juan José Segura-Egea; Eugenio Velasco-Ortega; José López-López
Journal:  Odontology       Date:  2015-03-22       Impact factor: 2.634

Review 2.  A case of age-related Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disorder, so-called polymorphous subtype, of the mandible, with a review of the literature.

Authors:  Kentaro Kikuchi; Shuichi Fukunaga; Harumi Inoue; Yuji Miyazaki; Masaru Kojima; Fumio Ide; Kaoru Kusama
Journal:  Head Neck Pathol       Date:  2012-08-07

Review 3.  Herpesviruses and MicroRNAs: New Pathogenesis Factors in Oral Infection and Disease?

Authors:  Afsar R Naqvi; Jennifer Shango; Alexandra Seal; Deepak Shukla; Salvador Nares
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

4.  Human cytomegalovirus is present in the odontogenic epithelium of ameloblastoma.

Authors:  Mohammed Amjed Alsaegh; Sudhir Rama Varma; Alaa Muayad Altaie; Shengrong Zhu
Journal:  J Oral Microbiol       Date:  2021-01-19       Impact factor: 5.474

5.  Detection of human cytomegalovirus and Epstein-Barr Virus in symptomatic and asymptomatic apical periodontitis lesions by real-time PCR.

Authors:  Selcuk-M Ozbek; Ahmet Ozbek; Muhammed-Selim Yavuz
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-09-01

6.  Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions.

Authors:  Sawako Shiraiwa; Yara Yukie Kikuti; Joaquim Carreras; Ryujiro Hara; Yasuyuki Aoyama; Daisuke Ogiya; Rikio Suzuki; Masako Toyosaki; Ken Ohmachi; Yoshiaki Ogawa; Hiroshi Kawada; Shinji Sato; Naoya Nakamura; Kiyoshi Ando
Journal:  J Clin Exp Hematop       Date:  2020-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.